These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 3524465
1. [Surgery and adjuvant therapy of non-small cell lung cancer]. Watanabe Y, Yamada T, Ichihashi T, Hashizume Y, Iwa T. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465 [Abstract] [Full Text] [Related]
2. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. Watanabe Y, Sato H, Iida S, Yamada T, Kobayashi H, Kimoto H, Tsunamura Y, Ichihashi T, Shimizu J, Hashizume Y. Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515 [Abstract] [Full Text] [Related]
5. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma. Kimura H, Yamaguchi Y. Cancer; 1997 Jul 01; 80(1):42-9. PubMed ID: 9210707 [Abstract] [Full Text] [Related]
10. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR. J Thorac Cardiovasc Surg; 2004 Jan 01; 127(1):108-13. PubMed ID: 14752420 [Abstract] [Full Text] [Related]
11. [Clinical significance of immunotherapy for lung cancer--present and future]. Watanabe Y, Shimizu J, Oda M, Yoshida M, Watanabe S, Iwa T. Nihon Geka Gakkai Zasshi; 1991 Sep 01; 92(9):1217-20. PubMed ID: 1944190 [Abstract] [Full Text] [Related]
12. [Combined therapy for stage IIIa non-small cell lung cancer]. Zhao LQ, Hou SC, Li H, Hu B, Wang Y. Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2030-2. PubMed ID: 16313794 [Abstract] [Full Text] [Related]
13. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan. Jpn J Clin Oncol; 1995 Jun 03; 25(3):91-103. PubMed ID: 7596054 [Abstract] [Full Text] [Related]
14. [Different treatment modalities of patients with stage III lung cancer]. Yu DP, Duan Y, Wang ZT. Zhonghua Yi Xue Za Zhi; 2009 Aug 04; 89(29):2056-8. PubMed ID: 20017330 [Abstract] [Full Text] [Related]
15. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group. J Thorac Cardiovasc Surg; 2003 Feb 04; 125(2):254-60. PubMed ID: 12579093 [Abstract] [Full Text] [Related]
16. [Clinical evaluation of bronchial artery infusion (BAI) in lung cancer]. Tanaka N, Kuramitsu T, Uchisako H, Nakaki H, Ito K, Nishikawa H, Suda H, Nakamura H, Suga K, Matsumoto T. Gan To Kagaku Ryoho; 1991 Apr 04; 18(4):613-8. PubMed ID: 1901476 [Abstract] [Full Text] [Related]
17. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)]. Li Q, Gao JM, Liang PY, Xie FY, Liu GZ. Ai Zheng; 2004 Nov 04; 23(11 Suppl):1463-6. PubMed ID: 15566658 [Abstract] [Full Text] [Related]
18. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer. Sakamoto J, Teramukai S, Watanabe Y, Hayata Y, Okayasu T, Nakazato H, Ohashi Y, Japanese Meta-Analysis Group in Cancer; in: Japanese Society of Strategies for Cancer Research and Therapy. J Immunother; 2001 Nov 04; 24(3):250-6. PubMed ID: 11394503 [Abstract] [Full Text] [Related]